328 related articles for article (PubMed ID: 23938262)
21. Serum microRNA expression levels in Turkish patients with Parkinson's disease.
Ozdilek B; Demircan B
Int J Neurosci; 2021 Dec; 131(12):1181-1189. PubMed ID: 32546033
[TBL] [Abstract][Full Text] [Related]
22. Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology.
Oliveira SR; Dionísio PA; Correia Guedes L; Gonçalves N; Coelho M; Rosa MM; Amaral JD; Ferreira JJ; Rodrigues CMP
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32585840
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
24. A panel of five circulating microRNAs as potential biomarkers for prostate cancer.
Chen ZH; Zhang GL; Li HR; Luo JD; Li ZX; Chen GM; Yang J
Prostate; 2012 Sep; 72(13):1443-52. PubMed ID: 22298030
[TBL] [Abstract][Full Text] [Related]
25. Plasma miR-203a-3p as a Novel Predictor of Dementia in Patients with Parkinson's Disease.
Hsu YF; Lin SP; Chu YT; Tsai YT; Huang JW; Phoa FKH; Wu RM
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542526
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs in Parkinson's disease: a systematic review and diagnostic accuracy meta-analysis.
Guévremont D; Roy J; Cutfield NJ; Williams JM
Sci Rep; 2023 Sep; 13(1):16272. PubMed ID: 37770507
[TBL] [Abstract][Full Text] [Related]
27. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K
Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710
[TBL] [Abstract][Full Text] [Related]
28. Identification of microRNAs for the early diagnosis of Parkinson's disease and multiple system atrophy.
Yan JH; Hua P; Chen Y; Li LT; Yu CY; Yan L; Zhang H; He Y; Zheng H; Chen H; Zhang ZJ; Yao QH; Dong H; Liu WG
J Integr Neurosci; 2020 Sep; 19(3):429-436. PubMed ID: 33070521
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide microRNA expression profiling in idiopathic non-obstructive azoospermia: significant up-regulation of miR-141, miR-429 and miR-7-1-3p.
Wu W; Qin Y; Li Z; Dong J; Dai J; Lu C; Guo X; Zhao Y; Zhu Y; Zhang W; Hang B; Sha J; Shen H; Xia Y; Hu Z; Wang X
Hum Reprod; 2013 Jul; 28(7):1827-36. PubMed ID: 23559187
[TBL] [Abstract][Full Text] [Related]
30. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
Gandhi R; Healy B; Gholipour T; Egorova S; Musallam A; Hussain MS; Nejad P; Patel B; Hei H; Khoury S; Quintana F; Kivisakk P; Chitnis T; Weiner HL
Ann Neurol; 2013 Jun; 73(6):729-40. PubMed ID: 23494648
[TBL] [Abstract][Full Text] [Related]
31. Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson's disease.
Trupp M; Jonsson P; Ohrfelt A; Zetterberg H; Obudulu O; Malm L; Wuolikainen A; Linder J; Moritz T; Blennow K; Antti H; Forsgren L
J Parkinsons Dis; 2014; 4(3):549-60. PubMed ID: 24927756
[TBL] [Abstract][Full Text] [Related]
32. Identification of predictive biomarkers for early diagnosis of larynx carcinoma based on microRNA expression data.
Wang Y; Chen M; Tao Z; Hua Q; Chen S; Xiao B
Cancer Genet; 2013; 206(9-10):340-6. PubMed ID: 24238754
[TBL] [Abstract][Full Text] [Related]
33. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer.
Wang WS; Liu LX; Li GP; Chen Y; Li CY; Jin DY; Wang XL
Cancer Prev Res (Phila); 2013 Apr; 6(4):331-8. PubMed ID: 23430754
[TBL] [Abstract][Full Text] [Related]
34. Plasma miR-21: a potential diagnostic marker of colorectal cancer.
Kanaan Z; Rai SN; Eichenberger MR; Roberts H; Keskey B; Pan J; Galandiuk S
Ann Surg; 2012 Sep; 256(3):544-51. PubMed ID: 22868372
[TBL] [Abstract][Full Text] [Related]
35. Circulating exosomal miRNAs as diagnostic biomarkers in Parkinson's disease.
Yao YF; Qu MW; Li GC; Zhang FB; Rui HC
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5278-5283. PubMed ID: 30178852
[TBL] [Abstract][Full Text] [Related]
36. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.
Barbagallo C; Mostile G; Baglieri G; Giunta F; Luca A; Raciti L; Zappia M; Purrello M; Ragusa M; Nicoletti A
Cell Mol Neurobiol; 2020 May; 40(4):531-546. PubMed ID: 31691877
[TBL] [Abstract][Full Text] [Related]
37. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.
Tang D; Shen Y; Wang M; Yang R; Wang Z; Sui A; Jiao W; Wang Y
Eur J Cancer Prev; 2013 Nov; 22(6):540-8. PubMed ID: 23462458
[TBL] [Abstract][Full Text] [Related]
38. Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson's disease.
DeMarshall CA; Han M; Nagele EP; Sarkar A; Acharya NK; Godsey G; Goldwaser EL; Kosciuk M; Thayasivam U; Belinka B; Nagele RG;
Immunol Lett; 2015 Nov; 168(1):80-8. PubMed ID: 26386375
[TBL] [Abstract][Full Text] [Related]
39. Circulatory miR-223-3p Discriminates Between Parkinson's and Alzheimer's Patients.
Mancuso R; Agostini S; Hernis A; Zanzottera M; Bianchi A; Clerici M
Sci Rep; 2019 Jun; 9(1):9393. PubMed ID: 31253822
[TBL] [Abstract][Full Text] [Related]
40. Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival.
Silva J; García V; Zaballos Á; Provencio M; Lombardía L; Almonacid L; García JM; Domínguez G; Peña C; Diaz R; Herrera M; Varela A; Bonilla F
Eur Respir J; 2011 Mar; 37(3):617-23. PubMed ID: 20595154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
